Dr. Abdul Haque Ansari Presents Groundbreaking Research on Fibromyalgia at International Physiology Congress

Frankfurt, Germany – September 14, 2025 — Dr. Abdul Haque Ansari, Professor of Physiology at the College of Medicine, recently showcased his latest research findings at the prestigious 40th Congress of the International Union of Physiological Sciences (IUPS) in collaboration with Europhysiology, held in Frankfurt, Germany, from September 11 to 14, 2025.
Dr. Ansari’s presentation, titled “Psychological Factors, Genetic Association, and Novel Treatment Option in Fibromyalgia,” offered a comprehensive exploration of the multifactorial nature of fibromyalgia—a chronic and often misunderstood pain disorder. His work delves into the interplay between psychological stressors, genetic predispositions, and innovative therapeutic strategies, positioning it at the cutting edge of current physiological and clinical research.
Highlighting the role of emerging biomarkers and potential genetic markers linked to susceptibility, Dr. Ansari emphasized the importance of personalized medicine in the effective management of fibromyalgia. He also presented promising preliminary data on novel treatment approaches aimed at modulating neurophysiological pathways involved in chronic pain.
The conference, one of the most significant global gatherings in the field of physiology, brought together leading experts, researchers, and clinicians from around the world to discuss advances across the physiological sciences. Dr. Ansari’s work attracted considerable attention and sparked discussion on the future direction of fibromyalgia research and therapy.
Dr. Ansari’s travel to the conference was generously supported through funding from Texila American University, recognizing the university’s ongoing commitment to promoting high-impact international research and academic collaboration.
His participation and contribution not only reflect the growing international recognition of his work but also underscore the College of Medicine’s dedication to advancing research that addresses complex, real-world health challenges.